MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Celldex Therapeutics Company Profile (NASDAQ:CLDX)

Consensus Ratings for Celldex Therapeutics (NASDAQ:CLDX) (?)
Ratings Breakdown: 5 Hold Rating(s), 6 Buy Rating(s)
Consensus Rating:Buy (Score: 2.55)
Consensus Price Target: $16.70 (300.48% upside)

Analysts' Ratings History for Celldex Therapeutics (NASDAQ:CLDX)
Show:
DateFirmActionRatingPrice TargetActions
5/6/2016WedbushReiterated RatingNeutral$3.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/6/2016Jefferies GroupReiterated RatingHold$4.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/19/2016Cowen and CompanyReiterated RatingOutperform$12.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/19/2016Roth CapitalReiterated RatingBuy$7.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/8/2016Brean CapitalReiterated RatingBuy$24.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/8/2016HC WainwrightLower Price TargetBuy$25.00 -> $6.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/7/2016Leerink SwannDowngradeOutperform -> Market Perform$30.00 -> $4.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/7/2016OppenheimerDowngradeOutperform -> Market PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/7/2016GuggenheimDowngradeBuy -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/26/2016Cantor FitzgeraldLower Price TargetBuy$31.00 -> $25.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/1/2015WBB SecuritiesReiterated RatingBuy$30.00 -> $40.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/27/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha